This scientist-led startup is working on a cure for a common surgery complication

A complication from surgery can cost tens of thousands of dollars and require more surgery to correct — but a young Maryland startup is cooking up a more affordable and less invasive solution. Bethesda's Nostopharma LLC is developing a treatment for pathologic bone growth, the formation of new bone following surgeries, burns, injuries and other traumas. The complication affects 100,000 patients e very year, a patient cohort the company’s co-founders hope to benefit with their product. The partners,…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news